ARUNA BIO INC.

Company Snapshot

Founded: 2003

Entity Type: Private

Region: U.S.

Headquarter: Georgia, U.S.

Key Geographics: North America

Corporate Address: 184 Collins Industrial Boulevard Suite A, Athens Georgia 30601 U.S. Tel. +1-(678)-879-5264 www.arunabio.com

Company Overview

Aruna Bio, Inc. is a biotechnology company that develops neural exosome-based therapeutics for treating neurodegenerative diseases such as Alzheimer’s and other memory disorders. The company utilizes its proprietary neural exosome platform and manufacturing capability to advance a pipeline of neural exosome-based therapeutics by augmenting exosomes with RNA, oligonucleotides, antibodies, and small molecules. The company’s neural exosome platform can cross the blood-brain barrier and reach the disease site.

ARUNA BIO INC. In Reports

Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

BCC Research Market Report provides an overview of Exosome Diagnostics and Therapeutics Market scope of the study is global. Current and projected market forecasts during the forecast period (2023 to 2028).

View All Reports

ARUNA BIO INC. In News

Aruna Bio Announces FDA Clearance of IND for Lead Program AB126, Enabling the First Exosome to Enter in Human Clinical Trials for a Neurological Indication - BioInformant

BioInformant - Apr 06, 2024

Company's Business Segments

Neural Exosomes : The company provides therapeutic exosomes to treat complicated CNS conditions and diseases and control neurodegenerative conditions in patients.

Applications/End User Industries

Healthcare

Life Sciences